Back to Search Start Over

In Emilia Romagna the adoption of zoledronic acid to treat postmenopausal osteoporosis could be cost effective when compared to other bisfosfonates

Details

Language :
English
Database :
OpenAIRE
Accession number :
edsair.od......3686..6a01bbfcb17260af5cc0751034e671cc